Bioequivalence studies for GCC submission [Design Issues]

posted by professionalr – India, 2025-01-31 00:00 (13 d 10:37 ago) – Posting: # 24353
Views: 296

Hi friends,
Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

Thanks,
RP.

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
48 visitors (0 registered, 48 guests [including 9 identified bots]).
Forum time: 10:37 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5